These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5670525)

  • 1. [Metabolic aspects of a case of nephrotic syndrome].
    Maciejewski J; Waligóra A
    Wiad Lek; 1968 Jul; 21(13):1153-5. PubMed ID: 5670525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphometric studies of minimal proliferative intercapillary glomerulonephritis with and without the nephrotic syndrome].
    Schrader M; Bürkle V
    Pathologe; 1983 Mar; 4(2):88-91. PubMed ID: 6190158
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital nephrotic syndrome presenting with cerebral venous thrombosis, hypocalcemia, and seizures in the neonatal period.
    Fofah O; Roth P
    J Perinatol; 1997; 17(6):492-4. PubMed ID: 9447540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
    Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
    Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y; Yoshikawa N; Nakamura H
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution to the knowledge of the structural changes in lipids and lipoproteins in lipoid nephrosis].
    RAIMONDI A
    Rass Giuliana Med; 1959 Oct; 15():307-11. PubMed ID: 14435891
    [No Abstract]   [Full Text] [Related]  

  • 8. [The nephrotic syndrome caused by minimal lesions nephropathy and focal glomerulosclerosis. Morphological and clinical aspects].
    Barbiano Di Belgiojoso G; Bertoli S; Busnach G; Casanova S; Dal Col A; Confalonieri R; Galato R; Micoli G; Surian M; Minetti L
    Minerva Nefrol; 1981; 28(3):403-14. PubMed ID: 7329618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Group study on enzymes in kidney diseases with special reference to the activity of the blood serum and urine. IV. Lipoid nephrosis].
    BARABAN H
    Pol Arch Med Wewn; 1961; 31():1565-74. PubMed ID: 13864731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipoid nephrosis and nephrotic syndrome. Development and present status of the concepts].
    Faria CV
    Rev Hosp Clin Fac Med Sao Paulo; 1971 Apr; 26(2):43-8. PubMed ID: 5089429
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin III metabolism in two patients with a nephrotic syndrome caused by minimal chain nephritis and primary amyloidosis.
    Drijfhout HH; Knot EA; ten Cate JW
    Haemostasis; 1987; 17(5):286-92. PubMed ID: 3666586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoid nephrosis and nephrotic syndromes].
    DEVIN P
    J Sci Med Lille; 1963; 81():343-54. PubMed ID: 14027413
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nephrotic syndrome. Physiopathology, diagnosis, evaluation, treatment of lipoid nephrosis].
    Moulin B; Bouiller M; Hannedouche T
    Rev Prat; 2000 Oct; 50(16):1807-16. PubMed ID: 11103135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genuine lipoid nephrosis and the nephrotic syndrome].
    NASSAU E
    Dia Med; 1954 Aug; 26(56):1520-5. PubMed ID: 13220328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrotic syndrome. Physiopathology, diagnosis, development, treatment of lipoid nephrosis].
    Chabannier MH; Modesto A; Orfila C; Suc JM
    Rev Prat; 1996 Oct; 46(15):1907-15. PubMed ID: 8953847
    [No Abstract]   [Full Text] [Related]  

  • 17. Infantile nephrotic syndrome. Clinicopathological study of 11 cases.
    Kristal H; Lichtig C
    Isr J Med Sci; 1983 Jul; 19(7):626-30. PubMed ID: 6885347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria.
    Jonkers IJ; Bruijn JA; Vleming LJ
    Am J Kidney Dis; 2004 Oct; 44(4):773-7. PubMed ID: 15384031
    [No Abstract]   [Full Text] [Related]  

  • 20. Pefloxacin as first-line treatment in nephrotic syndrome.
    Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
    Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.